Australia markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
144.41-0.75 (-0.52%)
At close: 04:00PM EDT
144.41 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts21212221
Avg. Estimate-1.18-1.04-4.11-1.76
Low estimate-1.56-1.53-5.9-4.32
High estimate-0.27-0.09-0.961.36
Year ago EPS-1.4-2.21-3.52-4.11
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts20202523
Avg. Estimate427.16M464.05M1.85B2.33B
Low estimate405.65M435.5M1.78B1.88B
High estimate452.3M565.06M2.04B2.97B
Year ago sales319.29M318.75M1.83B1.85B
Sales growth (year/est)33.80%45.60%1.40%25.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.76-1.37-1.34-1.32
Actual EPS-1.4-2.211.15-1.1
Difference0.36-0.842.490.22
Surprise %20.50%-61.30%185.80%16.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.18-1.04-4.11-1.76
7 days ago-1.18-1.04-4.1-1.76
30 days ago-1.18-1.04-4.18-1.76
60 days ago-1.17-1.04-4.18-1.5
90 days ago-1.3-1.19-4.25-1.07
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2121
Growth estimatesALNYIndustrySector(s)S&P 500
Current qtr.15.70%N/AN/AN/A
Next qtr.52.90%N/AN/AN/A
Current year-16.80%N/AN/AN/A
Next year57.20%N/AN/AN/A
Next 5 years (per annum)-177.50%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A